131 related articles for article (PubMed ID: 20837945)
1. Perfusion magnetic resonance imaging for parametric response maps in tumors: is it really that easy?
Heiland S; Wick W; Bendszus M
J Clin Oncol; 2010 Oct; 28(29):e591; author reply e592. PubMed ID: 20837945
[No Abstract] [Full Text] [Related]
2. Parametric response map as an imaging biomarker to distinguish progression from pseudoprogression in high-grade glioma.
Tsien C; Galbán CJ; Chenevert TL; Johnson TD; Hamstra DA; Sundgren PC; Junck L; Meyer CR; Rehemtulla A; Lawrence T; Ross BD
J Clin Oncol; 2010 May; 28(13):2293-9. PubMed ID: 20368564
[TBL] [Abstract][Full Text] [Related]
3. Elevated peritumoural rCBV values as a mean to differentiate metastases from high-grade gliomas.
Blasel S; Jurcoane A; Franz K; Morawe G; Pellikan S; Hattingen E
Acta Neurochir (Wien); 2010 Nov; 152(11):1893-9. PubMed ID: 20799046
[TBL] [Abstract][Full Text] [Related]
4. Perfusion magnetic resonance imaging predicts patient outcome as an adjunct to histopathology: a second reference standard in the surgical and nonsurgical treatment of low-grade gliomas.
Law M; Oh S; Johnson G; Babb JS; Zagzag D; Golfinos J; Kelly PJ
Neurosurgery; 2006 Jun; 58(6):1099-107; discussion 1099-107. PubMed ID: 16723889
[TBL] [Abstract][Full Text] [Related]
5. Tissue characterization of glioma by proton magnetic resonance spectroscopy and perfusion-weighted magnetic resonance imaging: glioma grading and histological correlation.
Toyooka M; Kimura H; Uematsu H; Kawamura Y; Takeuchi H; Itoh H
Clin Imaging; 2008; 32(4):251-8. PubMed ID: 18603178
[TBL] [Abstract][Full Text] [Related]
6. Measurements of tumor vascular leakiness using DCE in brain tumors: clinical applications.
Jain R
NMR Biomed; 2013 Aug; 26(8):1042-9. PubMed ID: 23832526
[TBL] [Abstract][Full Text] [Related]
7. Dexamethasone and enhancing solitary cerebral mass lesions: alterations in perfusion and blood-tumor barrier kinetics shown by magnetic resonance imaging.
Wilkinson ID; Jellineck DA; Levy D; Giesel FL; Romanowski CA; Miller BA; Griffiths PD
Neurosurgery; 2006 Apr; 58(4):640-6; discussion 640-6. PubMed ID: 16575327
[TBL] [Abstract][Full Text] [Related]
8. Comparative study of methods for determining vascular permeability and blood volume in human gliomas.
Harrer JU; Parker GJ; Haroon HA; Buckley DL; Embelton K; Roberts C; Balériaux D; Jackson A
J Magn Reson Imaging; 2004 Nov; 20(5):748-57. PubMed ID: 15503330
[TBL] [Abstract][Full Text] [Related]
9. Opening the blood-brain and blood-tumor barriers in experimental rat brain tumors: the effect of intracarotid hyperosmolar mannitol on capillary permeability and blood flow.
Hiesiger EM; Voorhies RM; Basler GA; Lipschutz LE; Posner JB; Shapiro WR
Ann Neurol; 1986 Jan; 19(1):50-9. PubMed ID: 3080944
[TBL] [Abstract][Full Text] [Related]
10. Cerebral blood flow, blood volume, and vascular permeability of cerebral glioma assessed with dynamic CT perfusion imaging.
Eastwood JD; Provenzale JM
Neuroradiology; 2003 Jun; 45(6):373-6. PubMed ID: 12719953
[TBL] [Abstract][Full Text] [Related]
11. High cerebral blood volume in human gliomas predicts deletion of chromosome 1p: Preliminary results of molecular studies in gliomas with elevated perfusion.
Law M; Brodsky JE; Babb J; Rosenblum M; Miller DC; Zagzag D; Gruber ML; Johnson G
J Magn Reson Imaging; 2007 Jun; 25(6):1113-9. PubMed ID: 17520715
[TBL] [Abstract][Full Text] [Related]
12. Quantitative measurement of leakage volume and permeability in gliomas, meningiomas and brain metastases with dynamic contrast-enhanced MRI.
Lüdemann L; Grieger W; Wurm R; Wust P; Zimmer C
Magn Reson Imaging; 2005 Oct; 23(8):833-41. PubMed ID: 16275421
[TBL] [Abstract][Full Text] [Related]
13. Perfusion MR imaging: moving forward.
Sorensen AG
Radiology; 2008 Nov; 249(2):416-7. PubMed ID: 18936306
[No Abstract] [Full Text] [Related]
14. Distinguishing glioma recurrence from treatment effect after radiochemotherapy and immunotherapy.
Yang I; Huh NG; Smith ZA; Han SJ; Parsa AT
Neurosurg Clin N Am; 2010 Jan; 21(1):181-6. PubMed ID: 19944976
[TBL] [Abstract][Full Text] [Related]
15. [Magnetic resonance spectroscopy in gliomas].
Galanaud D; Chinot O; Metellus P; Cozzone P
Bull Cancer; 2005 Apr; 92(4):327-31. PubMed ID: 15888389
[TBL] [Abstract][Full Text] [Related]
16. Brain tumors: current issues in diagnosis and management.
Lyons MK; Vora SA
Semin Neurol; 2007 Sep; 27(4):312-24. PubMed ID: 17701868
[TBL] [Abstract][Full Text] [Related]
17. Real-time monitoring of gadolinium diethylenetriamine penta-acetic acid during osmotic blood-brain barrier disruption using magnetic resonance imaging in normal wistar rats.
Blanchette M; Pellerin M; Tremblay L; Lepage M; Fortin D
Neurosurgery; 2009 Aug; 65(2):344-50; discussion 350-1. PubMed ID: 19625914
[TBL] [Abstract][Full Text] [Related]
18. The parametric response map is an imaging biomarker for early cancer treatment outcome.
Galbán CJ; Chenevert TL; Meyer CR; Tsien C; Lawrence TS; Hamstra DA; Junck L; Sundgren PC; Johnson TD; Ross DJ; Rehemtulla A; Ross BD
Nat Med; 2009 May; 15(5):572-6. PubMed ID: 19377487
[TBL] [Abstract][Full Text] [Related]
19. Multimodal magnetic resonance imaging in the diagnosis and therapeutical follow-up of brain tumors.
Housni A; Boujraf S
Neurosciences (Riyadh); 2013 Jan; 18(1):3-10. PubMed ID: 23291791
[TBL] [Abstract][Full Text] [Related]
20. Partial-volume model for determining white matter and gray matter cerebral blood volume for analysis of gliomas.
Lee MC; Cha S; Chang SM; Nelson SJ
J Magn Reson Imaging; 2006 Mar; 23(3):257-66. PubMed ID: 16456821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
